EP 0822820 A1 19980211 - NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe)
Title (en)
NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe)
Title (de)
NEUE VERWENDUNG VON (S)-ADENOSYL-L-METHIONIN (SAMe)
Title (fr)
NOUVELLE UTILISATION DE (S)-ADENOSYL-L-METHIONINE (SAMe)
Publication
Application
Priority
- DE 19515275 A 19950426
- EP 9601570 W 19960413
Abstract (en)
[origin: WO9633727A1] The use of SAMe and its physiologically acceptable salts in doses of over 2000 mg per day and patient for the parenteral treatment of conditions triggered by focal permanent ischaemia.
IPC 1-7
IPC 8 full level
A61K 31/70 (2006.01); A61P 43/00 (2006.01)
IPC 8 main group level
A61K (2006.01)
CPC (source: EP KR)
A61K 31/70 (2013.01 - KR); A61K 31/7076 (2013.01 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 9633727A1
Designated contracting state (EPC)
AT BE CH DE ES FI FR GB IT LI NL SE
DOCDB simple family (publication)
WO 9633727 A1 19961031; AR 001687 A1 19971126; AU 5646396 A 19961118; CA 2216854 A1 19961013; CN 1182367 A 19980520; CZ 330597 A3 19980218; DE 19515275 A1 19961031; EP 0822820 A1 19980211; HR P960196 A2 19980228; IL 117844 A0 19960804; JP H11504023 A 19990406; KR 19990008061 A 19990125; MX 9707735 A 19971231; NO 974941 D0 19971024; NO 974941 L 19971024; ZA 963296 B 19971027
DOCDB simple family (application)
EP 9601570 W 19960413; AR 33625596 A 19960423; AU 5646396 A 19960413; CA 2216854 A 19960413; CN 96193498 A 19960413; CZ 330597 A 19960413; DE 19515275 A 19950426; EP 96913500 A 19960413; HR P960196 A 19960424; IL 11784496 A 19960408; JP 53213196 A 19960413; KR 19970707585 A 19971025; MX 9707735 A 19960413; NO 974941 A 19971024; ZA 963296 A 19960425